175
Participants
Start Date
January 24, 2019
Primary Completion Date
May 2, 2024
Study Completion Date
May 2, 2024
Docetaxel
Docetaxel will be administered.
Feladilimab
Feladilimab will be administered.
Ipilimumab
Ipilimumab will be administered.
GSK4428859A
GSK4428859A/EOS884448 will be administered.
Dostarlimab
Dostarlimab will be administered.
GSK6097608
GSK6097608 will be administered.
GSK Investigational Site, Orbassano to
GSK Investigational Site, Gyeonggi-do
GSK Investigational Site, Seongnam-si Gyeonggi-do
GSK Investigational Site, Caen
GSK Investigational Site, Berlin
GSK Investigational Site, Milan
GSK Investigational Site, Großhansdorf
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Pinehurst
GSK Investigational Site, Cheongju Chungcheongbuk-do
GSK Investigational Site, Málaga
GSK Investigational Site, Bordeaux
GSK Investigational Site, Kassel
GSK Investigational Site, Immenhausen
GSK Investigational Site, Nashville
GSK Investigational Site, Chattanooga
GSK Investigational Site, Santander
GSK Investigational Site, Seville
GSK Investigational Site, Saint-Herblain
GSK Investigational Site, Meldola FC
GSK Investigational Site, Ravenna
GSK Investigational Site, Siena
GSK Investigational Site, Heidelberg
GSK Investigational Site, Paris
GSK Investigational Site, Dallas
GSK Investigational Site, Paris
GSK Investigational Site, Napoli
GSK Investigational Site, Gauting
GSK Investigational Site, Los Angeles
GSK Investigational Site, Villejuif
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Craiova
GSK Investigational Site, Timișoara
GSK Investigational Site, Floreşti
GSK Investigational Site, Chelyabinsk
GSK Investigational Site, St Louis
GSK Investigational Site, The Bronx
GSK Investigational Site, Edmonton
GSK Investigational Site, Brampton
GSK Investigational Site, Toronto
GSK Investigational Site, Leipzig
GSK Investigational Site, Amsterdam
GSK Investigational Site, Maastricht
GSK Investigational Site, Lodz
GSK Investigational Site, Poznan
GSK Investigational Site, Warsaw
GSK Investigational Site, Bucharest
GSK Investigational Site, Otopeni
GSK Investigational Site, Seoul
GSK Investigational Site, Badajoz
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Stockholm
GSK Investigational Site, Uppsala
Lead Sponsor
iTeos Belgium SA
INDUSTRY
GlaxoSmithKline
INDUSTRY